1. Home
  2. DRDB vs MLAB Comparison

DRDB vs MLAB Comparison

Compare DRDB & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRDB
  • MLAB
  • Stock Information
  • Founded
  • DRDB 2024
  • MLAB 1982
  • Country
  • DRDB United States
  • MLAB United States
  • Employees
  • DRDB N/A
  • MLAB N/A
  • Industry
  • DRDB
  • MLAB Industrial Machinery/Components
  • Sector
  • DRDB
  • MLAB Industrials
  • Exchange
  • DRDB Nasdaq
  • MLAB Nasdaq
  • Market Cap
  • DRDB 315.3M
  • MLAB 341.1M
  • IPO Year
  • DRDB 2024
  • MLAB N/A
  • Fundamental
  • Price
  • DRDB $10.29
  • MLAB $61.15
  • Analyst Decision
  • DRDB
  • MLAB Buy
  • Analyst Count
  • DRDB 0
  • MLAB 2
  • Target Price
  • DRDB N/A
  • MLAB $113.50
  • AVG Volume (30 Days)
  • DRDB 88.2K
  • MLAB 113.5K
  • Earning Date
  • DRDB 01-01-0001
  • MLAB 11-06-2025
  • Dividend Yield
  • DRDB N/A
  • MLAB 1.01%
  • EPS Growth
  • DRDB N/A
  • MLAB N/A
  • EPS
  • DRDB N/A
  • MLAB N/A
  • Revenue
  • DRDB N/A
  • MLAB $242,351,000.00
  • Revenue This Year
  • DRDB N/A
  • MLAB $5.38
  • Revenue Next Year
  • DRDB N/A
  • MLAB $5.25
  • P/E Ratio
  • DRDB $588.40
  • MLAB N/A
  • Revenue Growth
  • DRDB N/A
  • MLAB 8.33
  • 52 Week Low
  • DRDB $9.87
  • MLAB $55.45
  • 52 Week High
  • DRDB $10.43
  • MLAB $155.12
  • Technical
  • Relative Strength Index (RSI)
  • DRDB N/A
  • MLAB 40.20
  • Support Level
  • DRDB N/A
  • MLAB $58.83
  • Resistance Level
  • DRDB N/A
  • MLAB $64.35
  • Average True Range (ATR)
  • DRDB 0.00
  • MLAB 3.34
  • MACD
  • DRDB 0.00
  • MLAB -0.07
  • Stochastic Oscillator
  • DRDB 0.00
  • MLAB 16.21

About DRDB Roman DBDR Acquisition Corp. II Ordinary shares

Roman DBDR Acquisition Corp II is a blank check company.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: